“Arcus Biosciences Announces Exciting New Employment Inducement Grants”
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company, has recently made an exciting announcement regarding the appointment of their new Chief Medical Officer, Richard Markus, M.D., Ph.D. As part of this appointment, Dr. Markus has been granted an option to purchase 305,328 shares of the company’s common stock. This move showcases the company’s commitment…